Divis Lab Q4 PAT rises 29% YoY to Rs 502 cr

Read more about Divis Lab Q4 PAT rises 29% YoY to Rs 502 cr on Business Standard. On a consolidated basis, Divi's Laboratories posted a 29.3% rise in net profit to Rs 502.02 crore in Q4 FY21 compared with Rs 388.23 crore in Q4 FY20.

Related Keywords

,Capital Market ,Pharmaceuticals Nec ,Divis Laboratories ,S 1 ,Pharmaceuticals Ingredients ,Major ,Apis ,C ,மூலதனம் சந்தை ,மருந்துகள் கழுத்து ,கள் ,பீஸ் ,